Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Clinical, hemispheric, and autonomic changes associated with use of closed-loop, allostatic neurotechnology by a case series of individuals with self-reported symptoms of post-traumatic stress

  • Charles H. Tegeler1,
  • Jared F. Cook1,
  • Catherine L. Tegeler1,
  • Joshua R. Hirsch1,
  • Hossam A. Shaltout2,
  • Sean L. Simpson3,
  • Brian C. Fidali1,
  • Lee Gerdes4 and
  • Sung W. Lee4Email author
BMC PsychiatryBMC series – open, inclusive and trusted201717:141

https://doi.org/10.1186/s12888-017-1299-x

Received: 8 August 2016

Accepted: 1 April 2017

Published: 19 April 2017

Abstract

Background

The objective of this pilot study was to explore the use of a closed-loop, allostatic, acoustic stimulation neurotechnology for individuals with self-reported symptoms of post-traumatic stress, as a potential means to impact symptomatology, temporal lobe high frequency asymmetry, heart rate variability (HRV), and baroreflex sensitivity (BRS).

Methods

From a cohort of individuals participating in a naturalistic study to evaluate use of allostatic neurotechnology for diverse clinical conditions, a subset was identified who reported high scores on the Posttraumatic Stress Disorder Checklist (PCL). The intervention entailed a series of sessions wherein brain electrical activity was monitored noninvasively at high spectral resolutions, with software algorithms translating selected brain frequencies into acoustic stimuli (audible tones) that were delivered back to the user in real time, to support auto-calibration of neural oscillations. Participants completed symptom inventories before and after the intervention, and a subset underwent short-term blood pressure recordings for HRV and BRS. Changes in temporal lobe high frequency asymmetry were analyzed from baseline assessment through the first four sessions, and for the last four sessions.

Results

Nineteen individuals (mean age 47, 11 women) were enrolled, and the majority also reported symptom scores that exceeded inventory thresholds for depression. They undertook a median of 16 sessions over 16.5 days, and 18 completed the number of sessions recommended. After the intervention, 89% of the completers reported clinically significant decreases in post-traumatic stress symptoms, indicated by a change of at least 10 points on the PCL. At a group level, individuals with either rightward (n = 7) or leftward (n = 7) dominant baseline asymmetry in temporal lobe high frequency (23–36 Hz) activity demonstrated statistically significant reductions in their asymmetry scores over the course of their first four sessions. For 12 individuals who underwent short-term blood pressure recordings, there were statistically significant increases in HRV in the time domain and BRS (Sequence Up). There were no adverse events.

Conclusion

Closed-loop, allostatic neurotechnology for auto-calibration of neural oscillations appears promising as an innovative therapeutic strategy for individuals with symptoms of post-traumatic stress.

Trials registration

ClinicalTrials.gov #NCT02709369, retrospectively registered on March 4, 2016.

Keywords

Post-traumatic stress Hemispheric asymmetry Temporal lobe Insula Brain electrical activity Heart rate variability Baroreflex sensitivity RDoC Neurotechnology Allostasis

Background

By most measures, there is room for improvement in the healthcare of individuals with symptoms of post-traumatic stress. Expert consensus statements in the last decade have held that psychotherapies for posttraumatic stress disorder (PTSD), based on controlled re-exposure to the traumatic event, are the most evidence-based treatment [1, 2]. However there are persisting concerns about this modality due to high rates of non-response and dropout [35]. Moreover, sleep disturbance is a core feature of PTSD [6] and a predictor of worse global functionality [7], yet sleep improvement is typically elusive after completion of PTSD-specific behavioral therapies [8, 9]. While SSRI and other medication prescriptions are common, the overall evidence for the efficacy of psychopharmacological agents for individuals with PTSD is generally considered to be modest at best [1, 10]. Editorialists have affirmed that “New innovative and engaging approaches for the treatment of PTSD are needed” [11].

Recently, a bihemispheric autonomic model (BHAM) has been proposed as an integrative approach to understanding the effects of traumatic stress on health and behavior [12, 13]. The BHAM begins by recognizing that the right and left hemispheres have differential responsibility for management of efferent sympathetic and parasympathetic activity, respectively, and this division of labor is represented most prominently at the bilateral insular cortices [14], which are deep to the temporal lobes. The BHAM posits that traumatic stress (physical or emotional) can produce a risk for the development of dominant and maladaptive asymmetries of brain activity in homologous regions of the hemispheres (insulae and elsewhere) that are involved with downstream regulation of the autonomic nervous system (ANS). Specifically, the experience of an activating traumatic stress may increase the risk for rightward dominant asymmetry that produces an autonomic bias for sympathetic fight-flight physiology. Repeated stressors – or a single overwhelming stress – may increase the risk for leftward dominant asymmetry that produces a parasympathetic freeze state, which may be associated with emotional numbing or dissociation.

The model’s attention to lateralized cortical management of the ANS aligns with the transdiagnostic, dimensional, and brain-based perspective that is encouraged by the RDoC initiative [15], and this focus can integrate findings which might have otherwise unappreciated relationships. For example, the BHAM predicts the observation that PTSD is associated with a range of physical health disorders [1618] including, effectively, accelerated physiological aging [19]. While the role of the ANS for mediating adverse behavioral and health states tends to be systematically under-recognized in clinical medicine [20], numerous researchers have used the metrics of heart rate variability (HRV) and baroreflex sensitivity (BRS), which are indicators of the capacity of the parasympathetic division to buffer sympathetic arousal, as a window on neural regulation of the cardiovascular system. Studies consistently show that HRV and BRS are diminished in patients with PTSD [2125].

Furthermore, the BHAM encourages new thinking in the domain of therapeutic strategy. A thesis of the model is that relative symmetry in the activity of bilateral cerebral hemispheric regions responsible for management of the autonomic nervous system (i.e. insulae and other regions of temporal cortex) is likely to be characterized by a state of relative autonomic optimality, associated with relatively small and healthy fluctuations between leftward and rightward asymmetry of activity in those regions. A corollary is that there may be value to interventions that can facilitate brain activity to calibrate away from maladaptive forms of hemispheric asymmetry, toward symmetry. Attenuation of rightward dominance in temporal lobe high frequency asymmetry has been reported from use of allostatic neurotechnology in individuals with insomnia, with a trend for reduction in asymmetry score to be associated with reduction in symptoms of sleep disturbance [26].

The objective of the present study was to evaluate the effects of closed-loop, allostatic, acoustic stimulation neurotechnology on clinical symptoms, temporal lobe high frequency electrical asymmetry, and autonomic cardiovascular regulation (HRV and BRS), in a case series of individuals with self-reported symptoms of post-traumatic stress. We hypothesized that use of the intervention would be associated with decreased levels of symptomatology, decreased temporal lobe high frequency electrical asymmetry, and improvements in parasympathetic measures of autonomic cardiovascular regulation. Temporal lobe asymmetry was chosen because of predictions associated with the BHAM, and a high frequency range of electrical activity was chosen in consideration of potential associations between trauma, sleep disturbance, and increased activity in this range [27, 28]. Secondarily we explored for possible relationships between baseline temporal lobe high frequency asymmetry, symptom severity, and heart rate variability. Changes in insomnia symptomatology and neurophysiological hyperarousal demonstrated by these individuals are reported elsewhere.

Methods

Participants

Participants were drawn from an ongoing, open label, exploratory protocol whose objective has been to identify clinical cohorts that may benefit from use of allostatic neurotechnology. The study is a single site IRB-approved project, carried out in the Department of Neurology at Wake Forest School of Medicine in Winston-Salem, North Carolina, USA. Participants with one or more neurological, cardiovascular, or psychophysiological conditions have been enrolled through clinician referrals and informal networks, producing a relatively open sampling frame that can support the advance of transdiagnostic clinical neuroscience research [15]. Exclusions are physical disability to attend study visits, known seizure disorders, total hearing impairment bilaterally, or ongoing use of benzodiazepine, opiate or anti-psychotic medications. Of 152 participants enrolled in the open label study between August 11, 2011 and April 28, 2014, nineteen participants reported a history of exposure to a traumatic stressor and identified symptoms related to post-traumatic stress as the primary reason for enrollment, and they comprise the cohort for the present report. Individuals met DSM-IV-TR [29] symptom criteria for PTSD on the basis of self-reported scores on PCL-C domains, rating “moderately” or above to at least one “B” item (intrusive recollection), at least three “C” items (avoidant/numbing), and at least two “D” items (hyperarousal). All nineteen participants reported more than one month duration of symptoms.

Neurotechnology-guided strategy for allostatic auto-calibration of neural oscillations

The intervention entailed use of a closed-loop, allostatic acoustic stimulation neurotechnology, intended to support auto-calibration of neural oscillations (High-resolution, relational, resonance-based, electroencephalic mirroring, or HIRREM® [26]; Brain State Technologies, Scottsdale, Arizona). HIRREM entails recording of brain electrical activity from scalp-based sensors, computer-guided algorithmic analysis of neural oscillatory frequencies for translation into sonic frequencies, and the return of acoustic signals back to the brain in real time (through the peripheral auditory nervous system). Procedures for the intervention have been discussed in detail previously [26]. Each participant began with a baseline assessment (45 min) to evaluate patterns of activity in the brain electrical frequency spectrum with respect to hemispheric symmetry, and ratios of energy across frequencies ranging from 0 to 48 Hz. The assessment consisted of two-channel recordings of brain electrical activity from at least six paired locations on the scalp (F3/F4, C3/C4, T3/T4, P3/P4, O1/O2, FZ/OZ; referenced to ears, linked), with the recipient at rest and while carrying out a task, using sensors and amplifiers (Brain State Technologies, Scottsdale, Arizona) that sample at 256 Hz. Recordings were conducted at each location with eyes closed (one minute), eyes partially open to permit transition in arousal state (one minute), and eyes open (one minute while performing a mental task, e.g. recalling numbers, reading a passage, etc.). Trained technologists evaluated assessment data to choose protocols for the initial intervention session. Protocols consisted of recording brain electrical activity through generally two channels, with sensors placed at homologous regions of the hemispheres (F3/F4, C3/C4, T3/T4, P3/P4, O1/O2, Fp1/Fp2) and also other locations depending on the judgment of the technologist. In real time, software algorithms analyzed specific ranges of the brain electrical frequency spectrum, identified dominant frequencies on the basis of proprietary mathematical formulae, and translated those frequencies to acoustic stimuli (audible tones of variable pitch and timing) which were presented to participants through standard earphones (Creative EP-630 or Sony Stereo Headphones MDR-EX58V) with as little as an eight millisecond delay. Volume (decibels) of acoustic stimulation was adjusted by each participant in accordance with their preference. The initial and subsequent sessions (approximately 90 min each) consisted of four to ten protocols (five to forty minutes each), some done with eyes closed and some with eyes open, with the participant being asked to relax while sitting or reclining comfortably in a zero-gravity chair. Specific protocols for successive sessions were chosen based on brain electrical data from the preceding session, which for purposes of technologist review was aggregated in broad-band frequency ranges (Hz; <1.0, 1.0–3.0, 3.0–5.5, 5.5–7.5, 7.5–10.0, 10.0–12.0, 12.0–15.0, 15.0–23.0, 23.0–36.0, 36.0–48.0). Brain regions were chosen with special attention to patterns of activity suggestive of dominant hemispheric asymmetries and/or suboptimal ratios of energy across the frequency spectrum [26]. Algorithms are designed to support de-establishment of relatively invariant and potentially maladaptive activity patterns. Participants generally completed two sessions in a half day, separated by a 20–30 min break. The decision for the total number of sessions to be received was based on impressions of clinical improvement or plateau, including evaluation of the participants’ brain pattern evolution over the course of their sessions, as well as the participants’ schedules and preferences. All participants continued with their usual medical or behavioral care. As a closed-loop strategy [30], HIRREM is explicitly designed to depend on brain activity as such, as opposed to the volition or learning skills of the client. Furthermore it is aligned with the allostasis model of physiological regulation, which recognizes the significance of neural regulation across organ systems, and the dependence of biological system functionality on the changing features of the local context [3134].

Measures of temporal lobe high frequency electrical asymmetry

One-minute epochs of brain electrical activity data from bilateral temporal lobes (T3 and T4 locations in the 10–20 International EEG system) were collected from the assessment and a temporal lobe exercise from each of the first four and final four sessions, in order to permit comparisons of activity from the early and latter phases of the intervention, for individuals who had differing numbers of total sessions. For each session, two epochs were analyzed, the first and the penultimate minute of the session. The penultimate minute was used to avoid potential recording artifacts related to completion of the final seconds of a given exercise (e.g. muscular contractions as participants became more alert). Tracings of amplitudes in ten frequency ranges (see Section 2.2) were visually inspected for sustained spikes or drops in amplitudes and cross-referenced with technologist session notes, to remove data that were considered to be potentially indicative of sensor displacement. Temporal lobe high frequency (23–36 Hz) asymmetry scores were calculated for each epoch by subtracting average amplitude at T3 from average amplitude at T4 and dividing by the lesser of the two. A positive asymmetry score indicates T4-dominance and a negative asymmetry score T3-dominance. On the basis of an a priori hypothesis about the significance of rightward versus leftward asymmetry in temporal lobe electrical activity [12], participants were divided into three groups according to their asymmetry scores at baseline assessment – T4 dominant (≥10%), T3 dominant (≤ − 10%), or balanced (absolute value < 10%). For each dominance group, change in asymmetry during the initial and latter stages of the intervention was evaluated in an exploratory way as follows. The slope of a fitted line was determined over the initial assessment and first four sessions, and the last four sessions, based on the median asymmetry scores over the course of those sessions. In order to assess whether these fitted lines reflected a tendency for change in asymmetry score, indicated as a positive or negative slope, a one-sample linear regression t-test was performed on each slope, with the null hypothesis being that it was zero. It should be noted that although this technique is common for interpreting the significance of a trend line, the underlying data consisted of median values for asymmetry scores and entailed intra-subject correlations, and thus the probability of randomness (p value) generated by this statistical test is best considered exploratory. Statistical tests were performed using SAS software version 9.3 (SAS Institute Inc., Cary, North Carolina, USA).

Symptom inventories for post-traumatic stress and depression

The Posttraumatic Stress Disorder Checklist (PCL-C; [35]) measures symptoms that may pertain to any traumatic life experience, and includes PTSD criteria B, C, & D measures from the DSM-IV-TR. Those with prior military service also completed the military version (PCL-M), which was used for reporting in the present paper. Seventeen items are rated on a Likert scale with a composite score range of 17–85, and a score of 44 or greater indicates a high likelihood for PTSD diagnosis [36]. A decrease of 10 points or greater in the PCL-C is considered a clinically significant improvement [37], and group-level change in PCL score was also analyzed through a paired t-test. Symptoms of depressive mood were evaluated by either the Center for Epidemiologic Studies Depression Scale (CES-D; [38]), or the Beck Depression Inventory (BDI; [39]). CESD scores range from 0 to 60, with a score of 16 or greater commonly used to indicate risk for clinically relevant depressive symptomatology. BDI scores range from 0 to 63, yielding classification of minimal depression (0–13), mild depression (14–19), moderate depression (20–28), and severe depression (29–63; [40]), and a score of 14 or greater was used as the threshold value. Post-HIRREM symptom data were collected within two weeks of the final HIRREM session.

Assessment of heart rate variability and baroreflex sensitivity

For twelve subjects, short-term (5 min, 1000 Hz) continuous blood pressure and heart rate recordings (BIOPAC, Santa Barbara, CA) were collected under conditions of spontaneous breathing, within thirty minutes prior to the baseline HIRREM assessment, and within two weeks after completing the final HIRREM session. Heart rate variability (HRV) was assessed as the standard deviation of the NN interval (SDNN) in the time domain and as the absolute values of the low and high frequency components. Baroreflex sensitivity (BRS) was assessed by the sequence method (Nevrokard BRS, Nevrokard Kiauta, Izola, Slovenia). Measures of autonomic cardiovascular regulation are presented as pre and post-HIRREM values and percentage differences, and comparisons were made using paired t-tests.

Relationships between temporal lobe high frequency asymmetry, heart rate variability, and clinical symptoms

Exploratory analysis was performed to detect possible relationships between temporal lobe high frequency electrical asymmetry and symptom severity or heart rate variability (SDNN). Each individual’s baseline SDNN value (when available) was plotted as a function of the temporal lobe high frequency asymmetry score from their HIRREM assessment, using a second-order polynomial regression equation. Similar analyses were conducted to detect possible relationships between temporal lobe high frequency asymmetry and the symptom inventory scores.

Results

Participants’ baseline characteristics, number of HIRREM sessions received, and scores on the PCL before and after the intervention are shown in Table 1. Mean age was 47 years (SD 14.9), 58% were women, and they reported a median of 3.5 years (range 3 months to 50 years) of symptoms after a traumatic event. All reported a history of multiple health conditions. 18 subjects provided both pre- and post-intervention data for the PCL and CES-D/BDI inventories. At baseline 95% reported symptom levels for depressive mood that exceeded the threshold for potential clinical significance. Participants received a median of 16 (range 6 to 26) HIRREM sessions over a median of 16.5 days (range 9 to 184), with a median of 8 days (range 5 to 14) of visits to the office to receive sessions. One participant elected to discontinue before the follow-up data collection visit, citing a lack of motivation and a preference to resume a previously discontinued medication regimen. After the intervention, 89% reported decreases of at least 10 points on the PCL, and as a group the mean change in their PCL scores was −24.1 (p < .0001). 33% exceeded the threshold values for depressive symptomatology. There were no adverse events.
Table 1

Gender, self-reported health conditions, and clinical course of study participants

Gender

Self-reported health conditions

Total number of sessions

Days in office/Total days start to finish

Pre-Intervention PCL score

Post-Intervention PCL score

M

Hypertension, anxiety, depression, insomnia, ADHD

11

6/10

57

28

F

Acutaneous lupus, anxiety, insomnia

17

14/39

67

33

M

Hypertension, headaches, depression, anxiety, insomnia, ADHD

12

8/11

63

53

M*

Anxiety, depression, insomnia

14

8/15

47a

22a

F

Bipolar disorder, insomnia

11

6/9

59

39

F

Depression, insomnia

26

13/184

56

28

F

Migraine, insomnia

6

5/9

53

n/a

M*

Traumatic brain injury, migraines, insomnia

22

12/13

76

58

F

Anxiety, migraines, insomnia

16

8/25

73

31

M*

Traumatic brain injury, migraines, depression, anxiety, insomnia

17

10/18

55

53

F

Traumatic brain injury, Headaches, fibromyalgia, insomnia

17

9/25

77

43

F

Fibromyalgia, headaches, depression, hot flashes

16

8/26

51

32

M*

Traumatic brain injury, insomnia, ADHD

12

6/8

71

21

F

Traumatic brain injury, chronic pain, migraine, tinnitus, depression, insomnia

16

8/10

81

76

F

Hypothyroidism, seasonal affective disorder, hot flashes, anxiety, insomnia

19

11/26

51

24

M*

Traumatic brain injury, headaches, tinnitus, anxiety, insomnia

16

8/10

48

30

F

Hyperlipidemia, tinnitus, anxiety, insomnia, depression, ADHD, hot flashes

13

8/12

47

19

M*

Hypertension, hyperlipidemia, diabetes, cancer, chronic pain, tinnitus, anxiety, insomnia

18

10/59

40

28

F

Headaches, anxiety

16

11/39

58

26

*Trauma related to prior military service, for whom symptom changes are reported using PCL-M

aScores are based on PCL-C

Changes in temporal lobe high frequency (23–36 Hz) electrical asymmetry are shown in Figs. 1 and 2. For the group of individuals who were rightward (T4) dominant (≥10%) at baseline, the slope of the trend line from the assessment through the first four sessions was negative (p = .023), indicating movement toward greater symmetry. Conversely, the group of individuals who were leftward (T3) dominant (≤ − 10%) at baseline demonstrated a positive slope in the trend line (p = .015) for their early sessions, also indicating movement toward greater symmetry. No statistically significant change in the asymmetry scores was shown for the group that did not have dominant asymmetry at baseline (<10% in either direction) over their early sessions, or for any of the groups over their final four sessions. For illustrative purposes, bilateral temporal lobe spectrographs for activity at baseline and during the penultimate minute of the fourth HIRREM session are shown for individuals whose baseline asymmetry was rightward (Fig. 3) and leftward (Fig. 4).
Fig. 1

Initial scores for temporal lobe high frequency (23–36 Hz) asymmetry. Panels show median asymmetry scores for baseline assessment (hashmark 1 on horizontal axis) through the first four sessions (first and penultimate minutes of each session, hashmarks 2 through 9). Vertical axes indicate asymmetry scores, with positive and negative values indicating rightward and leftward asymmetry, respectively. Top panel shows data for participants whose baseline temporal lobe high frequency asymmetry was 10% or greater toward the right (n = 7); middle panel shows those whose baseline asymmetry was 10% or greater toward the left (n = 7); bottom shows those whose baseline asymmetry was less than 10% in either direction (n = 5)

Fig. 2

Later scores for temporal lobe high frequency (23–36 Hz) asymmetry. Panels show median asymmetry scores for the last four sessions (first and penultimate minutes of each session, hashmarks 1 through 8). See Fig. 1 legend for explanation of other elements

Fig. 3

Spectrographs of bilateral temporal lobe electrical activity for a 71 year old male Vietnam War veteran with PTSD and multiple co-morbidities, from baseline assessment (a) and penultimate minute of the fourth HIRREM session (b). Data were collected from bilateral temporal lobes (T3 and T4 in the 10–20 International EEG system), with frequency (Hz, vertical axis) plotted against amplitude (microvolts, μv, horizontal axis). Individual color bars reflect amplitude averages for one minute of recording, eyes closed, at rest, without stimulation. Columns to the left and right of the color bars denote ten frequency ranges of aggregated data (Hz, 00: <1.0; 10: 1.0–3.0; 20: 3.0–5.5; 30: 5.5–7.5; 40: 7.5–10.0; 50: 10.0–12.0; 60: 12.0–15.0; 70: 15.0–23.0; 80: 23.0–36.0; 90: 36.0–48.0) and numerical values for averages in those ranges

Fig. 4

Spectrographs of bilateral temporal lobe electrical activity for a 50 year old woman with a history PTSD, migraine, and insomnia, from baseline assessment (a) and penultimate minute of the fourth HIRREM session (b). See Fig. 3 legend for detailed description of data elements

For the twelve participants who underwent short-term blood pressure recordings before and after HIRREM, values for measures of autonomic cardiovascular regulation are shown in Table 2. There were statistically significant increases in heart rate variability as measured in the time domain (SDNN) and baroreflex sensitivity (Sequence Up – indicative of lengthening of the RR interval with increasing blood pressure). Exploratory analysis demonstrated a significant negative correlation between rightward temporal lobe high frequency asymmetry at baseline assessment and SDNN (F-test p = .0014), as shown in Fig. 5. There was no statistically significant relationship between temporal lobe high frequency asymmetry and symptom scores for post-traumatic stress or depression (data not shown).
Table 2

Changes in measures of autonomic cardiovascular regulation after use of closed-loop allostatic neurotechnology

 

Mean value at baseline (SD)

Mean value after HIRREM (SD)

P value

BRS Sequence Up [ms/mmHg]

13.2 (11.0)

17.3 (12.6)

0.009

BRS Sequence Down

[ms/mmHg]

14.5 (9.6)

17.5 (17.8)

>0.2

BRS Sequence All

[ms/mmHg]

13.9 (9.7)

18.0 (15.8)

>0.2

SDNN [ms]

46.2 (29.2)

53.4 (32.0)

0.026

LF [ms2]

1407 (2094)

2100 (3702)

>0.2

HF [ms2]

881 (1778)

1048 (2510)

>0.2

MAP [mmHg]

96.8 (4.5)

94.3 (9.8)

>0.2

HR [bpm]

63.3 (11.3)

65.3 (10.4)

>0.2

BRS Baroreflex sensitivity, SDNN Standard deviation of the normal beat-to-beat interval, LF Low Frequency, HF High Frequency, MAP Mean arterial pressure, HR Heart rate

Fig. 5

Fit plot of heart rate variability (vertical axis) versus temporal lobe high frequency asymmetry score (horizontal axis), at baseline. Data are from 12 individuals who underwent short-term blood pressure recordings prior to beginning use of allostatic neurotechnology. SDNN = standard deviation of the NN interval. Asymmetry scores greater than zero indicate rightward asymmetry, less than zero indicate leftward asymmetry

Discussion

In this case series, individuals with self-reported symptoms of post-traumatic stress undertook use of an allostatic neurotechnology for closed-loop auto-calibration of neural oscillations. After completing a series of sessions, the majority of participants reported clinically significant reductions in their symptoms of post-traumatic stress and depressive mood. Analysis of high-frequency (23–36 Hz) brain electrical activity patterns at the bilateral temporal lobes showed that at a group level, those who had either rightward or leftward asymmetry at their baseline assessment became more symmetrical over their first four sessions. In a subset of the participants for whom short-term blood pressure recordings were collected, statistically significant improvements were demonstrated in HRV in the time domain as well as BRS, suggesting increased parasympathetic capacity. The intervention was well tolerated, with 18 of 19 participants completing their course of sessions as recommended by the provider team.

The present findings are consistent with earlier studies reporting reductions in temporal lobe high frequency asymmetry, improvements in heart rate variability, or both, in the course of allostatic neurotechnology usage by adults with insomnia [41], adolescents with postural orthostatic tachycardia syndrome (POTS; [42]), and athletes with persisting post-concussion symptoms [43]. Other neurotechnologies proposed for treatment of PTSD include stimulatory techniques such as transcranial magnetic stimulation (TMS; [44]) and transcranial direct current stimulation (TDCS; [45]), which are open-loop approaches in that they do not record brain activity before delivering successive cycles of their intervention. EEG operant conditioning [4648] is a form of reward-based training to achieve conscious self-management of brain rhythms (“learner-in-the-loop”), and a recent study found that receiving 40 sessions was associated with a significant but incomplete degree of PTSD symptom reduction [48].

The negative correlation at baseline between rightward temporal high frequency asymmetry and HRV is consistent with a report on the larger and more heterogeneous sample from which this case series was drawn [49], which contended that temporal lobe high frequency electrical asymmetry holds promise as a physiological unit of analysis for the RDoC domain of arousal. In contrast, the absence of a relationship between this metric and post-traumatic stress symptom severity gives preliminary indication that it is unlikely to be sufficient as a stand-alone biomarker of clinical PTSD status. This assessment is tempered by recognition that the participants had numerous comorbid health conditions which may have had independent effects on their asymmetry patterns. Others have reported that state-dependent brain electrical asymmetry during trauma-relevant stimulation is more likely than trait asymmetry under neutral conditions, to identify individuals with PTSD [50, 51].

Prima facie, we interpret the reduction in temporal lobe high frequency asymmetry over the first four sessions as a reflection of auto-calibration of neural oscillations [26]. In conjunction with the increased HRV and BRS that were demonstrated after completion of the sessions, the movement toward symmetry is consistent with a thesis of the BHAM that was noted in the Introduction. Increasing symmetry in temporal lobe high frequency electrical activity may have represented enhanced, centrally-directed, parasympathetic modulation of sympathetic arousal. If an effect on the core biology of autonomic regulation is shown to be durable and replicable in future studies, it would represent a genuine therapeutic advance. To date, there have been reports of improved HRV in patients with PTSD in association with usage of fluoxetine [52], behavioral therapy [53], HRV biofeedback [54], and eye movement desensitization and reprocessing [55]; other recent studies in military service members with PTSD have found that mindfulness meditation had no impact on HRV [56], and escitalopram was associated with HRV reduction [57].

An important limitation to the present study derives from its case series design and the absence of a control group. Above all, it could be conjectured that the results were primarily due to subjective expectation for benefit, positive provider-client interactions, regression to the mean, natural history of disease, or a combination of these factors. Nonetheless the physiological changes in temporal lobe electrical asymmetry and autonomic cardiovascular regulation tend to stand against this explanation, considering that placebo interventions in clinical research are less likely to impact objective outcome measures [58]. An additional limitation of the study is that the participant selection was based on their self-reported history and score on the PCL, and did not include a clinician assessment.

Conclusion

In conclusion, this study found that individuals with self-reported symptoms of post-traumatic stress who undertook use of a closed-loop, allostatic, acoustic stimulation neurotechnology, reported significant reductions in clinical symptomatology that were accompanied by reductions in temporal lobe high frequency electrical asymmetry, and increased HRV and BRS. These improvements, in conjunction with the absence of adverse events or significant drop-outs, suggest that neurotechnology-assisted auto-calibration of neural oscillations holds promise as an innovative therapeutic strategy for individuals with symptoms related to post-traumatic stress.

Declarations

Acknowledgments

The authors acknowledge Lindsay J. Howard, and Krystal D. Schmidt, for assistance with provision of the study intervention, and organization and preparation of data for analysis.

Funding

This study was supported by a research grant from The Susanne Marcus Collins Foundation, Inc., and the National Institute of Biomedical Imaging and Bioengineering K25 EB012236-01A1 (Simpson). Funding bodies had no role in either the design of the study; collection, analysis, or interpretation of data; or writing of the manuscript.

Availability of data and materials

Datasets analyzed for the current study are available from the corresponding author on reasonable request.

Authors’ contributions

CHT conceived the study design and objectives, and contributed to data analysis and co-drafting of manuscript. JC, JH, and BF contributed to data analysis and critical revision of manuscript. CL oversaw intervention delivery, data collection, and contributed to data analysis. SS performed statistical analysis. HS performed initial analysis of autonomic data. LG was responsible for development of the intervention methodology. SL contributed to data analysis and co-drafting of manuscript. All authors read and approved the final manuscript.

Competing interests

Dr. Lee and Mr. Gerdes are employees and shareholders at Brain State Technologies, developers of the allostatic neurotechnology evaluated in the study. The other authors report no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The study was approved by the Institutional Review Board of Wake Forest School of Medicine, and all participants provided informed consent prior to participation.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Neurology, Wake Forest School of Medicine, Medical Center Boulevard
(2)
Hypertension and Vascular Research Center, Wake Forest School of Medicine, Medical Center Boulevard
(3)
Department of Biostatistical Sciences, Wake Forest School of Medicine, Medical Center Boulevard
(4)
Brain State Technologies

References

  1. Committee on Treatment of Posttraumatic Stress Disorder, Institute of Medicine. Treatment of posttraumatic stress disorder: an assessment of the evidence. Washington, D.C.: National Academies Press; 2008.Google Scholar
  2. Jonas DE, Cusack K, Forneris CA, Wilkins TM, Sonis J, Middleton JC et al. Psychological and pharmacological treatments for adults with posttraumatic stress disorder (PTSD). Rockville MD: Agency for Healthcare Research and Quality; 2013.Google Scholar
  3. Schottenbauer MA, Glass CR, Arnkoff DB, Tendick V, Gray SH. Nonresponse and dropout rates in outcome studies on PTSD: review and methodological consideration. Psychiatry. 2008;71:134–68.View ArticlePubMedGoogle Scholar
  4. Steenkamp MM, Litz BT, Hoge CW, Marmar CR. Psychotherapy for military-related PTSD: a review of randomized clinical trials. JAMA. 2015;314:489–500.View ArticlePubMedGoogle Scholar
  5. Najavits LM. The problem of dropout from ‘gold standard’ PTSD therapies. F1000Prime Reports. 2015;7:43.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Spoormaker VI, Montgomery P. Disturbed sleep in post-traumatic stress disorder: secondary symptom or core feature? Sleep Med Rev. 2008;12:169–84.View ArticlePubMedGoogle Scholar
  7. Brownlow JA, McLean CP, Gehrman PR, Harb GC, Ross RJ, Foa EB. Influence of sleep disturbance on global functioning after posttraumatic stress disorder treatment. J Trauma Stress. 2016;29:515–21.View ArticlePubMedGoogle Scholar
  8. Belleville G, Guay S, Marchand A. Persistence of sleep disturbances following cognitive-behavior therapy for posttraumatic stress disorder. J Psychosom Res. 2011;70:318–27.View ArticlePubMedGoogle Scholar
  9. Pruiksma KE, Wachen JS, Peterson AL, Borah EV, Litz BT, Resick PA, et al. Residual sleep disturbances following PTSD treatment in active duty military personnel. Psychol Trauma. 2016;8:697–701.View ArticlePubMedGoogle Scholar
  10. Bernardy NC, Friedman MJ. Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): what have we learned? Curr Psychiatry Rep. 2015;17:20.View ArticleGoogle Scholar
  11. Kearney DJ, Simpson TL. Broadening the approach to posttraumatic stress disorder and the consequences of trauma. JAMA. 2015;314:453–5.View ArticlePubMedGoogle Scholar
  12. Lee SW, Gerdes L, Tegeler CL, Shaltout HA, Tegeler CH. A bihemispheric autonomic model for traumatic stress effects on health and behavior. Front Psychol. 2014;5:843.PubMedPubMed CentralGoogle Scholar
  13. Ginsberg JP. Editorial: Dysregulation of autonomic cardiac control by traumatic stress and anxiety. Front Psychol. 2016;7:945.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Oppenheimer SM, Gelb A, Girvin JP, Hachinski VC. Cardiovascular effects of human insular cortex stimulation. Neurology. 1992;42:1727–32.View ArticlePubMedGoogle Scholar
  15. Cuthbert BN, Insel T. (2013). Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013;11:126.Google Scholar
  16. Parcella ML, Hruska B, Delahanty DL. The physical health consequences of PTSD and PTSD symptoms: a meta-analytic review. J Anxiety Disord. 2013;27:33–46.View ArticleGoogle Scholar
  17. Farr OM, Ko BJ, Joung KE, Zaichenko L, Usher N, Tsoukas M, et al. Posttraumatic stress disorder, alone or additively with early life adversity, is associated with obesity and cardiometabolic risk. Nutr Metab Cardiovasc Dis. 2015;25:479–88.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Beristianos MH, Yaffe K, Cohen B, Byers AL. PTSD and risk of incident cardiovascular disease in aging veterans. American Journal of Geriatric Psychiatry. 2014; Dec 9, Epub ahead of print.Google Scholar
  19. Williamson JB, Porges EC, Lamb DG, Porges SW. Maladaptive autonomic regulation in PTSD accelerates physiological aging. Front Psychol. 2015;5:1571.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Rees CA. Lost among the trees? The autonomic nervous system and paediatrics. Arch Dis Child. 2014;99:552–62.View ArticlePubMedGoogle Scholar
  21. Cohen H, Kotler M, Matar MA, Kaplan Z, Miodownik H, Cassuto Y. Power spectral analysis of heart rate variability in posttraumatic stress disorder patients. Biol Psychiatry. 1997;41:627–9.View ArticlePubMedGoogle Scholar
  22. Hughes JW, Dennis MF, Beckham JC. Baroreceptor sensitivity at rest and during stress in women with posttraumatic stress disorder or major depressive disorder. J Trauma Stress. 2007;20:667–76.View ArticlePubMedGoogle Scholar
  23. Chang HA, Chang CC, Tzeng NS, Kuo TB, Lu RB, Huang SY. Decreased cardiac vagal control in drug-naïve patients with posttraumatic stress disorder. Psychiatry Investigation. 2013;10:121–30.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Shah AJ, Lampert R, Goldberg J, Veledar E, Bremner JD, Vaccarino V. Posttraumatic stress disorder and impaired autonomic modulation in male twins. Biol Psychiatry. 2013;73:1103–10.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Norte CE. L Souza GG, Vilete L, Marques-Portella C, F Coutino ES, Figueira I, Volchan E. They know their trauma by heart: an assessment of psychophysiological failure to recover in PTSD. J Affect Disord. 2013;150:136–41.View ArticlePubMedGoogle Scholar
  26. Gerdes L, Gerdes P, Lee SW, Tegeler CH. HIRREM: a noninvasive, allostatic methodology for relaxation and auto-calibration of neural oscillations. Brain and Behavior. 2013;3:193–205.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Sinha SS. Trauma-induced insomnia: a novel model for trauma and sleep research. Sleep Med Rev. 2016;25:74–83.View ArticlePubMedGoogle Scholar
  28. Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M, Nissen C. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev. 2010;14:19–31.View ArticlePubMedGoogle Scholar
  29. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed., Text revision. Washington, D.C.: American Psychiatric Association; 2000.Google Scholar
  30. Krook-Magnuson E, Gelinas JN, Soltesz I, Buzsaki G. Neuroelectronics and biooptics: closed-loop technologies in neurological disorders. JAMA Neurol. 2015;72:823–9.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Sterling P, Eyer J. Allostasis: a new paradigm to explain arousal pathology. In: Fisher S, Reason J, editors. Handbook of life stress, cognition, and health. Oxford: Wiley; 1988. p. 629–49.Google Scholar
  32. Sterling P. Principles of allostasis: optimal design, predictive regulation, pathophysiology, and rational therapeutics. In: Schulkin J, editor. Allostasis, homeostasis, and the costs of physiological adaptation. New York: Cambridge University Press; 2004. p. 17–64.View ArticleGoogle Scholar
  33. Sterling P. Allostasis: a model of predictive regulation. Physiol Behav. 2012;106:5–15.View ArticlePubMedGoogle Scholar
  34. Sterling P. Homeostasis versus allostasis: implications for brain function and mental disorders. JAMA Psychiatry. 2014;71:1192–3.View ArticlePubMedGoogle Scholar
  35. Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM. The PTSD Checklist (PCL): reliability, validity, and diagnostic utility. In: 9th annual meeting of the International Society for Traumatic Stress Studies; 1993.Google Scholar
  36. Blanchard EB, Jones-Alexander J, Buckley TC, Forneris CA. Psychometric properties of the PTSD Checklist (PCL). Behav Res Ther. 1996;34:669–73.View ArticlePubMedGoogle Scholar
  37. Monson CM, Gradus JL, Young-Xu Y, Schnurr PP, Price JL, Schumm JA. Change in posttraumatic stress disorder symptoms: do clinicians and patients agree? Psychol Assess. 2008;20:131–8.View ArticlePubMedGoogle Scholar
  38. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.View ArticleGoogle Scholar
  39. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression. New York: Guilford Press; 1979.Google Scholar
  40. Smarr KL. Measures of depression and depressive symptoms: the Beck depression inventory (BDI), Center for Epidemiological Studies-Depression Scale (CES-D), geriatric depression scale (GDS), hospital anxiety and depression scale (HADS), and primary care evaluation of mental disorders-mood module (PRIME-MD). Arthritis Care & Res. 2003;49:S134–46.View ArticleGoogle Scholar
  41. Tegeler CH, Kumar S, Conklin D, Lee SW, Gerdes EL, Turner DP, Tegeler CL, Fidali B, Houle TT. Open label, randomized, crossover pilot trial of high resolution, relational, resonance-based, electroencephalic mirroring (HIRREM) to relieve insomnia. Brain Behav. 2012;2:814–24.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Fortunato JE, Tegeler CL, Gerdes L, Lee SW, Pajewski NM, Franco ME, et al. Use of an allostatic neurotechnology by adolescents with postural orthostatic tachycardia syndrome is associated with improvements in heart rate variability and changes in temporal lobe electrical activity. Exp Brain Res. 2016;234:791–8.View ArticlePubMedGoogle Scholar
  43. Tegeler CH, Tegeler CL, Cook JF, Lee SW, Gerdes L, Shaltout HA, Miles CM, Simpson SL. A preliminary study of the effectiveness of an allostatic, closed-loop, acoustic stimulation neurotechnology in the treatment of athletes with persisting post-concussion symptoms. Sports Medicine – Open. 2016;2:39.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Clark C, Cole J, Winter C, Williams K, Grammer G. A review of transcranial magnetic stimulation as a treatment for post-traumatic stress disorder. Current Psychiatry Reports. 2015;17:83.View ArticlePubMedGoogle Scholar
  45. Saunders N, Downham R, Turman B, Kropotov J, Clark R, Yumash R, et al. Working memory training with tDCS improves behavioral and neurophysiological symptoms in pilot group with post-traumatic stress disorder (PTSD) and with poor working memory. Neurocase. 2015;21:271–8.View ArticlePubMedGoogle Scholar
  46. Peniston EG, Kulkosky PJ. Alpha-theta brainwave neuro-feedback for Vietnam veterans with combat-related post-traumatic stress disorder. Med Psychol. 1991;4:47–60.Google Scholar
  47. Kluetsch RC, Ros T, Theberge J, Frewen PA, Calhoun VD, Schmahl C, et al. Plastic modulation of PTSD resting-state networks and subjective well-being by EEG neurofeedback. Acta Psychiatr Scand. 2014;130:123–36.View ArticlePubMedGoogle Scholar
  48. Gapen M, van der Kolk BA, Hamlin E, Hirshberg L, Suvak M, Spinazzola J. A pilot study of neurofeedback for chronic PTSD. Applied Psychophysiology and Biofeedback. 2016; Jan 19, Epub ahead of print.Google Scholar
  49. Tegeler CH, Shaltout HA, Tegeler CL, Gerdes L, Lee SW. Rightward dominance in temporal high-frequency electrical asymmetry corresponds to higher resting heart rate and lower baroreflex sensitivity in a heterogeneous population. Brain and Behavior. 2015;5:e00343.View ArticlePubMedPubMed CentralGoogle Scholar
  50. Rabe S, Beauducel A, Zollner T, Maercker A, Karl A. Regional brain electrical activity in posttraumatic stress disorder after motor vehicle accident. J Abnorm Psychol. 2006;115:687–98.View ArticlePubMedGoogle Scholar
  51. Meyer T, Smeets T, Giesbrecht T, Quaedflieg CW, Smulders FT, Meijer EH, et al. The role of frontal EEG asymmetry in post-traumatic stress disorder. Biol Psychol. 2015;108:62–77.View ArticlePubMedGoogle Scholar
  52. Cohen H, Kotler M, Matar M, Kaplan Z. Normalization of heart rate variability in post-traumatic stress disorder patients following fluoxetine treatment: preliminary results. Isr Med Assoc J. 2000;2:296–301.PubMedGoogle Scholar
  53. Nishith P, Duntley SP, Domitrovich PP, Uhles ML, Cook BJ, Stein PK. Effect of cognitive behavioral therapy on heart rate variability during REM sleep in female rape victims with PTSD. J Traum Stress. 2003;16:247–50.View ArticleGoogle Scholar
  54. Zucker TL, Samuelson KW, Muench F, Greenberg MA, Gevirtz RN. The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study. Appl Psychophysiol Biofeedback. 2009;34:134–43.View ArticleGoogle Scholar
  55. Farina B, Imperatori C, Quintiliani MI, Gattinara PC, Onofri A, Lepore M, et al. Neurophysiological correlates of eye movement desensitization and reprocessing sessions: preliminary evidence for traumatic memories integration. Clin Physiol Funct Imaging. 2015;35:460–8.View ArticlePubMedGoogle Scholar
  56. Wahbeh H, Goodrich E, Goy E, Oken BS. Mechanistic pathways of mindfulness meditation in combat veterans with posttraumatic stress disorder. J Clin Psychol. 2016;72:365–83.View ArticlePubMedPubMed CentralGoogle Scholar
  57. Ramaswamy S, Selvaraj V, Driscoll D, Madabushi JS, Bhatia SC, Yeragani V. Effects of escitalopram on autonomic function in posttraumatic stress disorder among veterans of operations enduring freedom and Iraqi freedom (OEF/OIF). Innov Clin Neurosci. 2015;12:13–9.PubMedPubMed CentralGoogle Scholar
  58. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001;344:1594–602.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement